A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region's publicly funded health care systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Latin America across a 10-year period.
The COVID-19 pandemic in will cause a minimal decline in overall PV procedures and revenues in 2020.
What factors contribute to the market decline?
To what degree will the pandemic affect different PV device segments?
How soon will procedure volumes, sales, and revenues recover over the forecast period?
A meta-analysis was published in 2018 that showed an increased risk of death associated with paclitaxel-coated balloons and stents after 2 years.
What effect did data highlighting safety concerns with paclitaxel-coated devices have on the DCB and DES market?
How were other PTA balloon catheter markets affected by turmoil in the DCB market?
How has this study impacted physicians' perception of these products?
Competitors are developing DES and DCBs that do not use paclitaxel.
What companies are developing these products?
What impact will the approval of such products have on use of existing devices?
Endovascular treatment of PVD is increasing in Latin America.
Which country has the highest penetration of endovascular procedures?
What factors influence the selection of PV stents or PTA balloons for endovascular procedures among the Latin American countries covered?
Which country will see the highest procedural and market revenue growth?
Most segments in the Latin American PV device market continue to be dominated by large international manufacturers.
Which companies are the leading competitors in each of the PV device segments?
What competitive strategies can firms use to maintain and/or improve their competitive positions going forward?
- Peripheral Vascular Devices - Market Insights - Latin America
Author(s): Pankhil Gandhi, PharmD
Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.